TY - JOUR
T1 - Central interferon-α inhibits natural killer cytotoxicity through sympathetic innervation
AU - Take, S.
AU - Mori, T.
AU - Katafuchi, T.
AU - Hori, T.
N1 - Copyright:
Copyright 2004 Elsevier B.V., All rights reserved.
PY - 1993
Y1 - 1993
N2 - The brain has been known to produce high levels of interferon-α (IFN-α) during viral infections. We investigated the central and peripheral mechanisms of the brain IFN-α-induced suppression of natural killer (NK) cytotoxicity in the rat. The activity of NK cells in the spleen and the peripheral blood decreased 30-120 min after intracerebroventricular (icv) injection of recombinant human IFN-α of >1,000 U but not after its intraperitoneal injection. This effect was antagonized by pretreatment with icv naltrexone (NLTX). Splenic denervation was observed to completely abolish the IFN-α-induced suppression of NK activity, whereas bilateral adrenalectomy did not. Furthermore, this immunosuppression was blocked by an icv injection of an antagonist of corticotropin-releasing factor (CRF), α- helical CRF-(9-41). The icv injection of CRF resulted in reduced NK activity, which was not affected by NLTX. The results suggest that brain IFN-α activates the CRF system through central opioid receptors and thereby suppresses the NK cytotoxicity predominantly through splenic sympathetic innervation.
AB - The brain has been known to produce high levels of interferon-α (IFN-α) during viral infections. We investigated the central and peripheral mechanisms of the brain IFN-α-induced suppression of natural killer (NK) cytotoxicity in the rat. The activity of NK cells in the spleen and the peripheral blood decreased 30-120 min after intracerebroventricular (icv) injection of recombinant human IFN-α of >1,000 U but not after its intraperitoneal injection. This effect was antagonized by pretreatment with icv naltrexone (NLTX). Splenic denervation was observed to completely abolish the IFN-α-induced suppression of NK activity, whereas bilateral adrenalectomy did not. Furthermore, this immunosuppression was blocked by an icv injection of an antagonist of corticotropin-releasing factor (CRF), α- helical CRF-(9-41). The icv injection of CRF resulted in reduced NK activity, which was not affected by NLTX. The results suggest that brain IFN-α activates the CRF system through central opioid receptors and thereby suppresses the NK cytotoxicity predominantly through splenic sympathetic innervation.
UR - http://www.scopus.com/inward/record.url?scp=0027216733&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027216733&partnerID=8YFLogxK
M3 - Article
C2 - 8368401
AN - SCOPUS:0027216733
SN - 0363-6119
VL - 265
SP - R453-R459
JO - American Journal of Physiology
JF - American Journal of Physiology
IS - 2 34-2
ER -